Description
R-Equol is the diasteromer of S-Equol. Although S-equol is a naturally occuring isoflavone metabolite in humans, R-equol is not. However, both of these diasteromers are biologically active.
| Product Unit Size | Cost | Quantity | Stock |
|---|
R-Equol is the diasteromer of S-Equol. Although S-equol is a naturally occuring isoflavone metabolite in humans, R-equol is not. However, both of these diasteromers are biologically active.
| Cas No. | 221054-79-1 |
|---|---|
| Purity | ≥98% |
| Formula | C15H14O3 |
| Formula Wt. | 242.27 |
| Chemical Name | (3R)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-7-ol |
| IUPAC Name | (3R)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-7-ol |
| Synonym | (3R)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-7-ol |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Lephart E. Resveratrol, 4’ acetoxy resveratrol, R-equol, racemic equol or S-equol as cosmeceuticals to improve dermal health. Int J Mol Sci. 2017 Jun 3;18(6):1193. PMID: 28587197
Setchell K, Zhao X, Jha P, et al. The pharmacokinetic behavios of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers. Am J Clin Nutr. 2009 Oct;90(4):1029-1037. PMID: 19710188
Synthesis impurity
Peptide fragment, renin substrate, precursor to...
Acridine derivative, DNA intercalator; topoisom...
Induces apoptosis, DNA cleavage and strand brea...
Potential p53 activator or SIRT2 inhibitor.
Azapirone; α1-adrenergic and 5-HT1A partial ag...
Tetracycline; protein translation inhibitor.
Alkaloid compound found in Corydalis.
Phase II enzyme inducer; Nrf2 activator; antiox...
Statin; HMG-CoA reductase inhibitor, potential ...
Aromatase inhibitor.
SMAC mimetic; PXR agonist, IAP inhibitor.
Aza-anthracenedione, DNA intercalator; topoisom...
Mycotoxin produced by species of Fusarium; pote...
CDK4/6 inhibitor.
Synthetic peptide, retroviral envelope protein ...
Nucleoside (deoxyadenosine) analog; DNA chain t...
Potential ATP-sensitive K+ channel blocker, pot...
Fluoroquinolone; topoisomerase IV and bacterial...
HDAC1/2/3/11 inhibitor.